Research European Collaborative Project

HORIZON 21

Down syndrome and Alzheimer’s disease

Horizon 21 Consortium

Stop Alzheimer's before it starts

A european consortium with research teams from 11 different european sites, to develop clinical trials in order to prevent or delay Alzheimer’s disease in the population with Down syndrome.

KEY NUMBERS

0
CURRENT PROJECTS
0
COUNTRIES
0
RESEARCHERS INVOLVED
0
INCLUSIONS

WHO WE ARE?

The Horizon 21 Consortium was born from a collaboration between clinicians from various european centers offering a consultation dedicated to adults and seniors with Down syndrome.

This program aims at identifying the factors that influence the development of Alzheimer’s disease in persons with Down syndrome. The consortium wants also to develop cognitive assesment tools and biomarkers which could be relevant for clinical trials. Of course, the main objective is to prevent and/or delay the onset of Alzheimer’s disease in this specific population.

meeting-londres-novembre21-_2_
2021-06-06by martin@artmin.fr

Training for research

The consoritum had a zoom meeting on the 05.06.2021 with more than 40 participants for a full day of training…

Read more
2021-10-20by martin@artmin.fr

T21RS virtual international conference

The Horizon 21 consortium participated to the T21RS virtual conference on the 06.10.2021 (Symposium 5 : Alzheimer's disease and Down…

Read more
2021-11-22by martin@artmin.fr

Face to face meeting in London 4th and 5th of november 2021

Consortium’s members are going to meet in person for the first time since the beginning of the pandemic. The main…

Read more
2022-03-17by martin@artmin.fr

Meeting in Barcelona

The Horizon 21 consortium met in Barcelona on 14 and 15 March 2022 for two days of work and training.

Read more
2022-03-21by martin@artmin.fr

World Down Syndrome Day!

On March 21, we celebrate World Down Syndrome Day! The entire Horizon 21 consortium is joining this day by participating…

Read more
2022-10-25by Communcation

Meeting in Paris, 20th and 21st of october

The Horizon 21 research consortium met these 20th and 21st of october, in Paris, at the Institut Jérôme Lejeune. It was a…

Read more

Our Projects

Genetic markers

Large-scale genotyping of persons with Down syndrome in order to identify risk or protective factors of Alzheimer's disease.

Cognitive evaluation tools

Harmonisation of cognitive evaluation tools

Biological markers

e.g neurofilaments light analysis in plasma.

Sleep evaluation

Impact of Alzheimer’s disease on sleep of adults with Down syndrome.

Discover our Research Centers

9 Countries, 11 CENTERS
  • European Consortium
See the map